Perzinfotel

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePerzinfotel
Drug Alias Name培净福太perzinfotelumWAY-126090EAA-090
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDiabetes MellitusDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG